Literature DB >> 18315593

Regional specificity of magnetization transfer imaging in multiple sclerosis.

Christopher W Tjoa1, Ralph H B Benedict, Michael G Dwyer, Dominic A Carone, Robert Zivadinov.   

Abstract

BACKGROUND: The goal of this study was to develop and validate a method for generation of regional magnetization transfer ratio (MTR). We also studied the topography of MTR changes in multiple sclerosis (MS) and in normal controls (NC), and preliminarily examined the clinical usefulness of this method.
METHODS: We examined 45 patients with MS (relapsing remitting [RR] = 28 and secondary progressive[SP] = 17] and 19 NC. Mean disease duration was 14.3 years and median Expanded Disability Status Scale was 3.0. Regions of the brain were determined using semiautomated brain region extraction (SABRE). Twenty-six regional masks were automatically applied to MTR maps that were further split into gray matter (GM) and white matter (WM)compartments.
RESULTS: Mean MTR from 12 SABRE regions differed significantly between MS patients and NC. For WM, all regional mean MTRs differed significantly between RR, SP, and NC participants(P < .001). In regression analysis, only 3 regions remained significantly different when corrected for total T2-LV. The regression model predicting disability selected GM mean MTR of the right medial inferior frontal region (P = .031).
CONCLUSIONS: The study results showed that this regional MTR approach is reproducible, reliable and clinically relevant. MTI changes occur selectively in specific sub-regions.

Entities:  

Mesh:

Year:  2008        PMID: 18315593     DOI: 10.1111/j.1552-6569.2007.00198.x

Source DB:  PubMed          Journal:  J Neuroimaging        ISSN: 1051-2284            Impact factor:   2.486


  4 in total

Review 1.  Quantitative magnetization transfer imaging in relapsing-remitting multiple sclerosis: a systematic review and meta-analysis.

Authors:  Elizabeth N York; Michael J Thrippleton; Rozanna Meijboom; David P J Hunt; Adam D Waldman
Journal:  Brain Commun       Date:  2022-04-04

2.  Immunologic and MRI markers of the therapeutic effect of IFN-β-1a in relapsing-remitting MS.

Authors:  Yazhong Tao; Xin Zhang; Robert Zivadinov; Michael G Dwyer; Cheryl Kennedy; Niels Bergsland; Deepa Ramasamy; Jacqueline Durfee; David Hojnacki; Brooke Hayward; Fernando Dangond; Bianca Weinstock-Guttman; Silva Markovic-Plese
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2015-11-12

3.  Effect of treatment with interferon beta-1a on changes in voxel-wise magnetization transfer ratio in normal appearing brain tissue and lesions of patients with relapsing-remitting multiple sclerosis: a 24-week, controlled pilot study.

Authors:  Robert Zivadinov; Michael G Dwyer; Silva Markovic-Plese; Cheryl Kennedy; Niels Bergsland; Deepa P Ramasamy; Jacqueline Durfee; David Hojnacki; Brooke Hayward; Fernando Dangond; Bianca Weinstock-Guttman
Journal:  PLoS One       Date:  2014-03-13       Impact factor: 3.240

4.  Quantitative measures of walking and strength provide insight into brain corticospinal tract pathology in multiple sclerosis.

Authors:  Nora E Fritz; Jennifer Keller; Peter A Calabresi; Kathleen M Zackowski
Journal:  Neuroimage Clin       Date:  2017-02-20       Impact factor: 4.881

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.